Ładuje się......
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway
Dramatic advances in immune therapy have emerged as a promising strategy in cancer therapeutics. In addition to chemotherapy and radiotherapy, inhibitors targeting immune-checkpoint molecules such as cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death receptor-1 (PD-1) and its ligand (P...
Zapisane w:
| Wydane w: | J Biomed Sci |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894306/ https://ncbi.nlm.nih.gov/pubmed/31801525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-019-0588-8 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|